Stock 605199 HAINAN HULUWA PHARMACEUTICAL GROUP CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Hainan Huluwa Pharmaceutical Group Co., Ltd.

Equities

605199

CNE100004223

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 18:00:00 2024-05-22 EDT 		5-day change 1st Jan Change
11.3 CNY -2.50% Intraday chart for Hainan Huluwa Pharmaceutical Group Co., Ltd. -5.28% -25.46%
05-01 Huluwa Pharmaceutical Gets Nod to Register Two Drugs MT
04-26 Hainan Huluwa Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Business Summary

Hainan Huluwa Pharmaceutical Group Co Ltd is a China-based company principally involved in the research and development, manufacturing and sales of Chinese patent medicines and chemical drugs. Its products are used in the pharmaceutical fields of respiratory system, digestive system, systemic anti-infection, including pediatric lung heat cough asthma granules, bromhexine hydrochloride for injection, compound Banlangen granules, Keke tablets, omeprazole enteric-coated capsules , Changyanning (capsules and granules), omeprazole sodium for injection, sodium diisopropylamine dichloroacetate for injection and cefixime dispersible tablets, among others. The Company also provides gynecological medicine, cardiovascular system medicine and neurological system medicine preparation products. The Company operates its businesses in the domestic market.

Number of employees: 2,468

Sales per Business

CNY in Million2022Weight2023Weight Delta
Respiratory Medicine
59.9 %
933 61.6 % 1,140 59.9 % +22.26%
Digestive System Medicine
21.0 %
362 23.9 % 400 21.0 % +10.50%
Other Drugs
11.4 %
92 6.1 % 218 11.4 % +135.87%
Systemic Anti-infective Drugs
7.7 %
128 8.4 % 147 7.7 % +14.75%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
100.0 %
1,515 100.0 % 1,905 100.0 % +25.75%

Managers

Managers TitleAgeSince
Jing Ping Liu CEO
 Chief Executive Officer 54 07-11-30
Peng Xu CHM
 Chairman 61 10-02-28
Hui Yu DFI
 Director of Finance/CFO 40 22-07-07
Jun Ling Li BRD
 Director/Board Member 56 18-08-31
Bao Kun Wan BRD
 Director/Board Member 62 12-03-31
Ping Liu BRD
 Director/Board Member 51 12-02-29
Hai Yan Wang IRC
 Investor Relations Contact 37 20-02-29
Qing Tao Wang SEC
 Corporate Secretary 42 15-02-28

Members of the board

Members of the board TitleAgeSince
Gui Hua Wang BRD
 Director/Board Member 63 18-11-15
Jing Ping Liu CEO
 Chief Executive Officer 54 07-11-30
Ping Liu BRD
 Director/Board Member 51 12-02-29
Bao Kun Wan BRD
 Director/Board Member 62 12-03-31
Hui Yu DFI
 Director of Finance/CFO 40 22-07-07
Jun Ling Li BRD
 Director/Board Member 56 18-08-31
Qi Bo Tang BRD
 Director/Board Member 36 22-11-03
Shi Xian Wang BRD
 Director/Board Member 48 22-11-03
Qiu Yun Liu BRD
 Director/Board Member 45 22-11-03
Peng Xu CHM
 Chairman 61 10-02-28

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 400,108,752 83,526,717 ( 20.88 %) 0 20.88 %

Shareholders

NameEquities%Valuation
Jing Ping Liu
41.76 %
167,079,000 41.76 % 270 M ¥
Jin Hua Lu
19.26 %
77,075,460 19.26 % 124 M ¥
Xu Dong Tang
10.95 %
43,824,000 10.95 % 71 M ¥
Jie Cheng Tang
4.696 %
18,789,540 4.696 % 30 M ¥
Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt)
0.1047 %
418,900 0.1047 % 676 234 ¥
China Asset Management Co., Ltd.
0.0488 %
195,300 0.0488 % 315 275 ¥
Penghua Fund Management Co., Ltd.
0.0436 %
174,526 0.0436 % 281 739 ¥
China Southern Asset Management Co., Ltd.
0.0433 %
173,300 0.0433 % 279 760 ¥
Fullgoal Fund Management Co., Ltd.
0.0279 %
111,500 0.0279 % 179 996 ¥
GF Fund Management Co., Ltd.
0.0252 %
100,800 0.0252 % 162 722 ¥

Company contact information

Hainan Huluwa Pharmaceutical Group Co., Ltd.

8, Yaogu 4th Road Phase II, Yaogu Industrial Park

570311, Haikou

+

http://www.huluwayaoye.com
address Hainan Huluwa Pharmaceutical Group Co., Ltd.(605199)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sector Other Pharmaceuticals

1st Jan change Capi.
HAINAN HULUWA PHARMACEUTICAL GROUP CO., LTD. Stock Hainan Huluwa Pharmaceutical Group Co., Ltd.
-25.46% 640M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+37.96% 723B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+34.28% 595B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.66% 369B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.05% 332B
ABBVIE INC. Stock AbbVie Inc.
+2.62% 282B
ASTRAZENECA PLC Stock AstraZeneca PLC
+17.02% 244B
NOVARTIS AG Stock Novartis AG
+9.31% 208B
ROCHE HOLDING AG Stock Roche Holding AG
-5.07% 205B
PFIZER, INC. Stock Pfizer, Inc.
-0.26% 168B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 605199 Stock
  4. Company Hainan Huluwa Pharmaceutical Group Co., Ltd.